Dick G. Menzies - Publications

The impact of rifampin drug interactions on tuberculosis preventive treatment completion and safety.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: March 28, 2026

Growth Differentiation Factor-15 Could Predict Decreased Hemoglobin in Tuberculosis Treated With Linezolid-Containing Regimen.

Journal: The clinical respiratory journal

Published: February 11, 2026

Consultant Occupational Health Physicians' Consensus on fatigue risk management.

Journal: Occupational medicine (Oxford, England)

Published: February 02, 2026

Strength of ATLAS or lady luck in a sepsis management trial?

Journal: The Lancet. Infectious diseases

Published: January 11, 2026

Fluoroquinolones for TB preventive treatment of contacts exposed to persons with multidrug-resistant TB: a systematic review and meta-analysis.

Journal: IJTLD open

Published: January 09, 2026

Treatment Outcomes and Drug-Related Adverse Events Across Four Short-Course RR-TB Regimens in South Africa: A Retrospective Analysis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 09, 2025

Treatment outcomes and drug-related adverse events across four short-course RR-TB regimens in South Africa: A retrospective analysis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 09, 2025

Functional Outcomes, Lung health and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): study protocol for a multicentre, prospective cohort study in Canada.

Journal: BMJ open

Published: November 17, 2025

Diagnostic Performance of New Commercial Interferon-Gamma Release Assays for Mycobacterium tuberculosis Infection: An Updated Systematic Review and Meta-analysis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 07, 2025

Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.

Journal: The Journal of infectious diseases

Published: October 17, 2025

Global status of policies and practices for systematic TB screening in high-burden countries.

Journal: IJTLD open

Published: June 30, 2025

Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial.

Journal: Open forum infectious diseases

Published: June 06, 2025